Unusual Pediatric Illness Emerging in the US and Europe, Surveillance System Activated Domestically

Jung Eun-kyung, Head of the Central Disaster and Safety Countermeasures Headquarters for COVID-19 <이미지:Yonhap News>

[Asia Economy Reporter Choi Dae-yeol] In relation to the pediatric multisystem inflammatory syndrome reported in the United States and Europe, also known as the mysterious pediatric disease, domestic authorities have decided to activate a surveillance network together with relevant experts. While establishing criteria for which cases qualify, they have also instructed that suspected cases be reported to the authorities.

Jung Eun-kyung, head of the Central Disease Control Headquarters, stated at a briefing on the 25th, "From today, we will operate a surveillance and investigation system for pediatric multisystem inflammatory syndrome associated with COVID-19," adding, "We reviewed overseas cases and collected expert opinions domestically to understand the current situation in Korea and respond promptly."

This disease was first reported in Europe in April and, as of the 23rd, has spread to 13 countries. It shows symptoms similar to Kawasaki disease, an acute febrile rash illness usually occurring in children under 4 years old, and in severe cases, it is known to lead to death; however, the exact cause has not yet been identified.

According to the case definition prepared by the authorities, multisystem inflammatory syndrome can be suspected in children and adolescents aged 19 or younger who have a fever of 38 degrees Celsius or higher lasting more than 24 hours, with blood test results confirming inflammatory symptoms or involvement of two or more organ systems requiring hospitalization due to severe condition.

Furthermore, if no other pathogens causing inflammation are identified, and all three conditions are met?evidence of current or recent COVID-19 infection, or exposure to COVID-19 within 4 weeks prior to onset?then the disease is defined as such by the health authorities. They have urged all medical institutions to immediately report any suspected cases of multisystem inflammatory syndrome among patients to the authorities.